BioBlood: M&A in the Biotech World

Abstract

The case focuses on the process of discovery, valuation, and deal structure in the acquisition of a small privately held company by a much larger company, both in the biotechnology industry. The case is written from the perspective of the head of business development for the larger company, William O'Brien. The case also provides richer details in how an acquirer prepares and structures a bid.